EP3415517
Kristallaform af 1-(4-1-(2,6-díflúoróbensýl)-5-dímetýlamínómetýl-3-(6-metoxýpýridasín-3-ýl)-2,4-díoxó-1,2,3,4-tetrahýdróþíenó(2,3-d)-pýrimídín-6-ýl)fenýl)-3-metoxýúrea
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.9.2013EP published:
20.4.2022EP application number:
18185835.8
EP translation filed:
28.4.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
26.9.2033Expiry date:
26.9.2026Next due date:
30.9.2026
Title in English:
CRYSTALLINE FORM OF 1-(4-1-(2,6-DIFLUOROBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-6YL)PHENYL)-3-METHOXYUREALanguage of the patent:
English
Timeline
Today
27.9.2013EP application
20.4.2022EP Publication
28.4.2022Translation submitted
15.6.2022Registration published
26.9.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
MIWA, KazuhiroAddress:
Osaka-shi, Osaka 532-0024, JP
Name:
SASAKI, TsuyoshiAddress:
Osaka-shi, Osaka 532-0024, JP
Name:
KOMURA, FumiyaAddress:
Osaka-shi, Osaka 532-0024, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2012217679Date:
28.9.2012Country:
JP
Classification
Categories:
C07D 495/04, A61P 5/02, A61P 15/08
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 15.7.2022
Expires: 26.9.2023
Payer: Patice ehf.
Number: 11
Paid: 12.9.2023
Expires: 26.9.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 17.9.2024
Expires: 26.9.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 17.9.2025
Expires: 26.9.2026
Payer: Árnason Faktor ehf.